BioCardia reported earnings of -$ 0.12 per BCDA share on Nov 12, 2026, falling short of analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 0.13 |
| Earnings Per Share (Surprise) | -$ 0.12 (+$ 0.01) |
| Last Year's EPS | -$ 0.32 |
| EPS YoY Change |
Out of the last 100 earnings reporting periods, BioCardia beat analysts’ expectations 14 times and fell short of expectations 13 time(s). BioCardia reported earnings per share of -$ 0.12 in the last report surpassing an estimated EPS of -$ 0.13 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.13 | -$ 0.12 | -$ 0.24 | |
| Aug 12, 2026 | -$ 0.18 | -$ 0.13 | -$ 0.40 | |
| May 15, 2026 | -$ 0.17 | -$ 0.21 | -$ 0.59 | |
| Mar 24, 2026 | -$ 0.20 | -$ 0.06 | -$ 0.25 | |
| Nov 12, 2025 | -$ 0.25 | -$ 0.24 | -$ 0.61 | |
| Aug 11, 2025 | -$ 0.25 | -$ 0.40 | -$ 0.88 | |
| May 14, 2025 | -$ 0.39 | -$ 0.59 | -$ 1.35 | |
| Mar 26, 2025 | -$ 0.87 | -$ 0.25 | -$ 1.35 | |
| Nov 13, 2024 | -$ 1.19 | -$ 0.61 | -$ 1.80 | |
| Aug 13, 2024 | -$ 0.10 | -$ 0.88 | -$ 2.55 | |
| May 14, 2024 | -$ 3.00 | -$ 1.35 | -$ 2.55 | |
| Mar 27, 2024 | -$ 1.65 | -$ 1.35 | -$ 2.40 | |
| Nov 8, 2023 | -$ 1.80 | -$ 1.80 | -$ 2.55 | |
| Aug 9, 2023 | -$ 2.25 | -$ 2.55 | -$ 2.10 | |
| May 10, 2023 | -$ 1.95 | -$ 2.55 | -$ 2.85 | |
| Mar 29, 2023 | -$ 2.70 | -$ 2.40 | -$ 0.21 | |
| Nov 9, 2022 | -$ 3.45 | -$ 2.55 | -$ 2.40 | |
| Aug 10, 2022 | -$ 4.20 | -$ 2.10 | -$ 3.00 | |
| May 11, 2022 | -$ 2.25 | -$ 2.85 | -$ 2.70 | |
| Mar 29, 2022 | -$ 0.21 | -$ 0.21 | -$ 2.40 |
BioCardia’s stock was trading at $ 0.9217 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, BCDA’s price decreased to $ 0.831 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.12 | $ 0.9217 | $ 0.831 | |
| Aug 12, 2026 | -$ 0.13 | $ 0.9321 | $ 0.9289 | |
| May 15, 2026 | -$ 0.21 | $ 1.09 | $ 0.9001 | |
| Mar 24, 2026 | -$ 0.06 | $ 1.20 | $ 1.20 | |
| Nov 12, 2025 | -$ 0.24 | $ 1.33 | $ 1.26 | |
| Aug 11, 2025 | -$ 0.40 | $ 1.79 | $ 1.74 | |
| May 14, 2025 | -$ 0.59 | $ 2.74 | $ 2.32 | |
| Mar 26, 2025 | -$ 0.25 | $ 2.63 | $ 2.68 | |
| Nov 13, 2024 | -$ 0.61 | $ 2.40 | $ 2.02 | |
| Aug 13, 2024 | -$ 0.88 | $ 2.53 | $ 2.59 | |
| May 14, 2024 | -$ 1.35 | $ 5.87 | $ 6.00 | |
| Mar 27, 2024 | -$ 1.35 | $ 6.30 | $ 6.11 | |
| Nov 8, 2023 | -$ 1.80 | $ 18.45 | $ 18.45 | |
| Aug 9, 2023 | -$ 2.55 | $ 38.46 | $ 40.74 | |
| May 10, 2023 | -$ 2.55 | $ 89.10 | $ 90.00 | |
| Mar 29, 2023 | -$ 2.40 | $ 97.65 | $ 87.30 | |
| Nov 9, 2022 | -$ 2.55 | $ 83.25 | $ 83.70 | |
| Aug 10, 2022 | -$ 2.10 | $ 66.84 | $ 71.10 | |
| May 11, 2022 | -$ 2.85 | $ 60.30 | $ 59.40 | |
| Mar 29, 2022 | -$ 0.21 | $ 92.25 | $ 93.15 |
BioCardia released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
BioCardia beat analysts’ expectations during the last earnings period by
